Login / Signup

Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients.

Wissam MekarySouha FaresFarah AbdulhaiGaelle MassoudMarwan RefaatMathias MericskayGeorge W BoozFouad A Zouein
Published in: Heliyon (2023)
Inhibition of the renin-angiotensin-aldosterone-system had no effect on the mortality of patients with COVID-19 and on their overall disease progression. However, it may be beneficial not to stop these medications as they decrease inflammation in the body and the levels of troponin, which are related to increased stress on the heart.
Keyphrases